The global diabetic footwear market size was valued at USD 5.78 billion in 2018 and is expected to grow at a compound annual growth rate (CAGR) of 7.6% from 2019 to 2025. These specialty goods are capable of preventing foot injuries caused by frequent mobility and removable shoe insole and inserts. Furthermore, these products are known for their adjustability due to the presence of stretchable material in their composition.
Rising usage of specialty shoes among the obese population to relieve pain and to provide relief from flat foot pain. Moreover, an increase in life expectancy along with awareness regarding the prevention of risks associated with obesity such as cardiovascular disorders and diabetes is projected to have a positive impact on the product demand.
Diabetic footwear is mostly used by the elderly population. Growing concerns over the side effects associated with synthetic medicines are changing the preference for safer alternatives. Consumers prefer diabetic footwear and other healthy remedies to reduce the impact of pre-diabetic cells. Technological advancements and medical upgrades are anticipated to bode well for market growth in the forthcoming years.
This specialty footwear available in inserted sole, flexible inner sole, and hybrid forms. Through this, the consumers are able to use this product for other purposes including posture improvement, relief from lower body pain, and also as protection from minor injuries capable of harming a diabetic person. This factor is projected to drive the product demand in the near future.
Shoes segment led the diabetic footwear market, accounting for 35.3% of global share in 2018. The segment is expected to witness growth owing to its increase use among the office-going population in developed markets including the U.S. and Germany. Furthermore, additional protection from foot injuries that reduce the occurrence of fungal infections is expected to drive the scope of growth in the near future.
Slippers segment is expected to witness the fastest CAGR of 8.3% from 2019 to 2025. These products are projected to foresee growth owing to their increased use in daily life. Furthermore, the launch of new products made using advanced materials such as leather, cotton, polyesters, and nylon is expected to open new growth avenues for the segment.
Offline channels are expected to reach USD 5.44 billion by 2025. Specialty stores and pharma outlets are expected to remain the key channels for customers to purchase diabetic footwear. Furthermore, urbanization and rising disposable income in emerging economies including China and India is expected to boost the spending on the establishment of new specialty outlets ensuring significant product supply along with other accessories.
Online segment is expected to hold 45% of global market share in terms of revenue by 2025, owing to increasing popularity of e-commerce portals as a means of product distribution to the buyers. Furthermore, the value-added services including, Cash-on-Delivery (COD), coupon benefits, and free home delivery by the e-commerce service providers such as Flipkart and Amazon is expected to boost the revenue share of the segment.
North America generated a revenue of USD 1.97 billion in 2018. Rising concerns regarding adverse effects associated with diabetic disorders among working class population of the U.S. and Canada are projected to have a strong impact. In addition, availability of products with advanced, excellent feet comfort features is expected to remain a favorable factor in the near future.
Asia Pacific is expected to witness a significant CAGR of 8.2% from 2019 to 2025. Changing lifestyle and fluctuating diet patterns among the middle-class population in emerging economies including China and India as a result of hectic work style is projected to drive awareness among consumers regarding the risk of obesity and related disorders. As a result, diabetic footwear is expected to find new growth avenues in the near future.
The Middle East and Africa is expected to reach more than USD 400 million by the end of 2025. Improvement in economic indicators of developing African countries such as Nigeria, Ethiopia, and Kenya as a result of urbanization and supportive government policies for infrastructure improvement on a domestic level is expected to force the footwear manufacturers to establish their strategic business units in vicinity over the next eight years.
Market leaders are expanding their geographical existence to get concentrated market share. Formation of strategies and collaborating with buyers to build new products is projected to remain a critical success factor over the next few years. Taking into account all these factors, manufacturers are likely to focus on product innovation. In January 2018, Sensoria and mobile garments manufacturer, Optima Molliter signed an agreement for the development of smart footwear products. These footwear are capable of measuring the compliance of diabetes patients’ to prescribed mechanical offloading protocols. Some of the prominent players in the diabetic footwear market include:
Podartis Srl
Aetrex Worldwide
DJO Global Inc.
Dr. Zen Products, Inc.
Orthofeet Inc
Report Attribute |
Details |
Market size value in 2020 |
USD 6.68 billion |
Revenue forecast in 2025 |
USD 9.66 billion |
Growth Rate |
CAGR of 7.6% from 2019 to 2025 |
Base year for estimation |
2018 |
Historical data |
2015 - 2017 |
Forecast period |
2019 - 2025 |
Quantitative units |
Revenue in USD million and CAGR from 2019 to 2025 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Product, distribution channel, region |
Regional scope |
North America; Europe; Asia Pacific; Central & South America; Middle East & Africa |
Country scope |
U.S.; Canada; Mexico; Germany; U.K.; France; India; China; Japan; Brazil; South Africa; U.A.E.; Saudi Arabia |
Key companies profiled |
Podartis Srl; Aetrex Worldwide; DJO Global Inc.; Dr. Zen Products, Inc.; Orthofeet Inc |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2015 to 2025. For the purpose of this study, Grand View Research has segmented the global diabetic footwear market report on the basis of product, distribution channel, and region:
Product Outlook (Revenue, USD Million, 2015 - 2025)
Slippers
Sandals
Shoes
Distribution Channel Outlook (Revenue, USD Million, 2015 - 2025)
Offline
Online
Regional Outlook (Revenue, USD Million, 2015 - 2025)
North America
The U.S.
Canada
Mexico
Europe
Germany
The U.K.
France
Asia Pacific
India
China
Japan
Central & South America
Brazil
Middle East & Africa
South Africa
U.A.E.
Saudi Arabia
b. The global diabetic footwear market size was estimated at USD 6.21 billion in 2019 and is expected to reach USD 6.68 billion in 2020.
b. The global diabetic footwear market is expected to grow at a compound annual growth rate of 7.6% from 2019 to 2025 to reach USD 9.66 billion by 2025.
b. North America dominated the diabetic footwear market with a share of 33.9% in 2019. This is attributable to rising concerns regarding the adverse effects associated with diabetic disorders among the working-class population worldwide.
b. Some key players operating in the diabetic footwear market include Etonic Worldwide LLC, Podartis Srl, DARCO International Inc, Aetrex Worldwide Inc., Apex Foot Health Industries LLC, Dr. Comfort LLC, and Advance Diabetic Solution.
b. Key factors that are driving the market growth include rising usage of specialty shoes among the obese population worldwide and increasing global awareness regarding the prevention of risks associated with obesity, such as cardiovascular disorders and diabetes.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."